New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
08:02 EDTDGX, SQNMSequenom and Quest Diagnostics announce collaboration agreement
Sequenom (SQNM) and Quest Diagnostics (DGX) announced an agreement under which Quest will offer national access to Sequenom Laboratories' MaterniT21 PLUS laboratory-developed test. Using a maternal blood sample, the noninvasive prenatal test analyzes chromosomal material in cell-free fetal DNA of pregnant women at increased risk for fetal chromosomal abnormalities. Quest expects to begin offering access to the test in the third quarter. In addition, Quest has formed a license agreement with Sequenom for certain NIPT patents and patent applications. The license agreement is the first formed by Sequenom with a commercial lab in the United States. Quest intends to use the intellectual property for the purposes of developing and validating its own proprietary lab-developed NIPT test. Quest expects to introduce this new offering in 2015. Additional terms of the agreement were not disclosed.
News For SQNM;DGX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 30, 2015
19:32 EDTDGXQuest to acquire MemorialCare's laboratory outreach service business
Quest Diagnostics and MemorialCare Health System announced they have entered into a definitive agreement for Quest to acquire MemorialCare Health System's laboratory outreach service business. The transaction is expected to be neutral to earnings in 2015. Quest and MemorialCare Health System expect to complete the acquisition in August. Financial terms were not disclosed.
07:56 EDTSQNMACOG opinion on NIPT not as bullish as hoped for Sequenom, says William Blair
Subscribe for More Information
June 23, 2015
10:00 EDTDGXOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:25 EDTDGXPiper Jaffray to hold a summit
2015 Piper Jaffray Heartland Summit is being held in Minneapolis on June 23-24.
06:13 EDTDGXQuest Diagnostics downgraded to Neutral from Buy at Goldman
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use